scholarly journals PDE3 inhibition with enoximone as first-line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report

2016 ◽  
Vol 5 (1) ◽  
pp. 18-21
Author(s):  
Robin van der Lee ◽  
Barbara Peels ◽  
Corine Koopman-Esseboom
Keyword(s):  
Pulmonary Hypertension ◽  
Case Report ◽  
Persistent Pulmonary Hypertension ◽  
First Line ◽  
Neonatal Transport ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Inhaled Iloprost as a First-Line Therapy for Persistent Pulmonary Hypertension of the Newborn

2019 ◽  
Vol 26 (4) ◽  
pp. 191-197
Author(s):  
Seung Hyun Kim ◽  
Hyun Ju Lee ◽  
Nam Su Kim ◽  
Hyun-Kyung Park
Keyword(s):  
Pulmonary Hypertension ◽  
Persistent Pulmonary Hypertension ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Inhaled Iloprost

Peritonitis as the First Presentation of Disseminated Listeriosis in a Patient on Peritoneal Dialysis—a Case Report

2017 ◽  
Vol 37 (2) ◽  
pp. 239-240 ◽  
Author(s):  
Weiwei Beckerleg ◽  
Vaibhav Keskar ◽  
Jolanta Karpinski
Keyword(s):  
Peritoneal Dialysis ◽  
Case Report ◽  
Listeria Monocytogenes ◽  
Empiric Therapy ◽  
Second Line ◽  
First Line ◽  
Systemic Involvement ◽  
First Line Therapy ◽  
Line Therapy ◽  
High Index Of Suspicion

Infections with Listeria monocytogenes are uncommon but serious, with mortality rate approaching 30% in cases of systemic involvement despite first-line therapy. They are usually caused by ingestion of contaminated foods, but spontaneous infections have also been described. Listeria monocytogenes is a rare cause of peritonitis, and most of the published cases are in patients with cirrhosis and ascites. There are a few reported cases of Listeria peritonitis associated with peritoneal dialysis (PD), primarily isolated peritonitis. If detected early, Listeria peritonitis can be successfully treated with ampicillin, alone or in combination with gentamicin. Vancomycin has been listed as a second-line agent. However, it has been associated with treatment failure. In this case report, we present a patient who developed disseminated listeriosis, with peritonitis as the first manifestation of disseminated infection. This case illustrates the importance of having a high index of suspicion for L. monocytogenes if patients deteriorate despite empiric therapy for PD-associated peritonitis and serves as a further example demonstrating the inadequate coverage of vancomycin for L. monocytogenes.

Capecitabine in Combination with Oxaliplatin as First-Line Therapy for Advanced Gastric Cancer: A Case Report

2011 ◽  
Vol 97 (1) ◽  
pp. 115-118 ◽  
Author(s):  
Rosario Mazzola ◽  
Massimiliano Alù ◽  
Vita Leonardi ◽  
Giuseppe Procopio ◽  
Biagio Agostara
Keyword(s):  
Gastric Cancer ◽  
Case Report ◽  
Advanced Gastric Cancer ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Efficacy and safety of Bosutinib in Patient with Chronic myeloid leukemia who was intolerant to DASTANIB,NILOTUNIB -Case report

2021 ◽  
Author(s):  
Abdullah Mohammad Arshad ◽  
mohamed yassin
Keyword(s):  
Case Report ◽  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Molecular Response ◽  
Efficacy And Safety ◽  
Major Molecular Response ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Bosutinib is approved as first line therapy for treatment of chronic phase CML and also in patients who are either resistant or intolerant to previous TKI. We present a 59 year old male who was intolerant to 2 TKI but showed excellent hematological and major molecular response to Bosutinib.

scholarly journals Resection as first-line therapy for large hepatic sclerosing hemangioma: a case report

2019 ◽  
Vol Volume 12 ◽  
pp. 6839-6842
Author(s):  
Li Xu ◽  
Xu Yang ◽  
Shan Ke ◽  
Xue-mei Ding ◽  
Shao-hong Wang ◽  
...  
Keyword(s):  
Case Report ◽  
First Line ◽  
Sclerosing Hemangioma ◽  
First Line Therapy ◽  
Line Therapy

Surgical management of amiodarone-induced thyrotoxicosis in a patient with Eisenmenger's syndrome: literature review and case report

2008 ◽  
Vol 123 (11) ◽  
pp. 1276-1279 ◽  
Author(s):  
R Pratap ◽  
A Qayyum ◽  
N Ahmad ◽  
P Jani
Keyword(s):  
Case Report ◽  
Surgical Management ◽  
World Literature ◽  
Surgical Intervention ◽  
Treatment Algorithm ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Eisenmenger’S Syndrome ◽  
Maximal Medical Therapy

AbstractObjective:We present a patient with a rare combination of amiodarone-induced thyrotoxicosis and Eisenmenger's syndrome.Method:Case report and review of the world literature regarding the morbidity and mortality of surgical management of amiodarone-induced thyrotoxicosis and the potential hazards of non-cardiac surgery in patients with Eisenmenger's syndrome.Results:Failure of maximal medical therapy necessitated surgical management to treat amiodarone-induced thyrotoxicosis which, in this particular patient, carried significant risks. Total thyroidectomy was performed leading to rapid resolution of thyrotoxicosis, and the patient made an uncomplicated recovery. We present this case because of its rarity and the potentially hazardous nature of surgical intervention in patients with Eisenmenger's syndrome. The pathogenesis of amiodarone-induced thyrotoxicosis and the differing approaches of medical and surgical management are discussed.Conclusion:Based on our findings, we propose that surgical management should be considered earlier in the treatment algorithm (or possibly as first-line therapy) for amiodarone-induced thyrotoxicosis.

Sign in / Sign up

Export Citation Format

Share Document